News
Patritumab deruxtecan shows promising survival rates and manageable safety in treating leptomeningeal metastatic disease, ...
Interdisciplinary GU Cancer Forum 2025, urothelial carcinoma, Metastatic Urothelial Carcinoma, enfortumab vedotin, advanced urothelial carcinoma when enfortumab vedotin, Optimal Sequence of Treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback